“…On one hand, gain-of-function mutations, that increase the late component of the Na + current (I Na ) and thus prolong the ventricular action potential, are responsible for the type 3 long QT syndrome (LQT3; Moss and Kass, 2005). On the other hand, loss-of-function mutations decrease I Na and are responsible for cardiac conduction diseases (Schott et al, 1999;Tan et al, 2001;Probst et al, 2003), Brugada syndrome (Gussak et al, 1999), sick sinus syndrome (Benson et al, 2003), and atrial standstill (Groenewegen et al, 2003). To complicate matters further, some SCN5A mutations can lead to more complex diseases associating different phenotypic traits such as, for instance, bradycardia, conduction disease, LQT3, and Brugada syndrome (so-called overlap syndromes; Bezzina et al, 1999;Kyndt et al, 2001;Grant et al, 2002;Rossenbacker et al, 2004;Smits et al, 2005; for review, see Remme et al, 2008).…”